Drug Shortage Report for TEVA-CLOPIDOGREL
| Report ID | 212720 |
| Drug Identification Number | 02388065 |
| Brand name | TEVA-CLOPIDOGREL |
| Common or Proper name | CLOPIDOGREL 300MG TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | CLOPIDOGREL |
| Strength(s) | 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | PP30 |
| ATC code | B01AC |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-12-06 |
| Estimated end date | 2024-06-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v24 | 2024-04-18 | French | Compare |
| v23 | 2024-04-18 | English | Compare |
| v22 | 2024-04-11 | French | Compare |
| v21 | 2024-04-11 | English | Compare |
| v20 | 2024-04-05 | French | Compare |
| v19 | 2024-04-05 | English | Compare |
| v18 | 2024-03-21 | French | Compare |
| v17 | 2024-03-21 | English | Compare |
| v16 | 2024-03-14 | French | Compare |
| v15 | 2024-03-14 | English | Compare |
| v14 | 2024-02-29 | French | Compare |
| v13 | 2024-02-29 | English | Compare |
| v12 | 2024-02-15 | French | Compare |
| v11 | 2024-02-15 | English | Compare |
| v10 | 2024-02-08 | French | Compare |
| v9 | 2024-02-08 | English | Compare |
| v8 | 2024-01-25 | French | Compare |
| v7 | 2024-01-25 | English | Compare |
| v6 | 2024-01-18 | French | Compare |
| v5 | 2024-01-18 | English | Compare |